『Better Biopharma』のカバーアート

Better Biopharma

Better Biopharma

著者: Tyler Menichiello
無料で聴く

このコンテンツについて

“How can biopharma improve?” This question is the guiding ethos of the Better Biopharma podcast. Through conversations with experts across the biopharma landscape, host Tyler Menichiello explores the work being done to make better medicines and optimize manufacturing. Each episode is a dive into the guest's methods, their curiosity, and their determination. By shining a light on the visionaries pushing the industry forward, Better Biopharma aims to inform and inspire their peers to continue doing the same.



© 2025 Better Biopharma
生物科学 科学
エピソード
  • Engineering Bacterial Vector-Based Immunotherapies With OS Therapies’ Paul Romness and Robert Petit, Ph.D.
    2025/10/08

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by OS Therapies’ CEO, Paul Romness, and chief medical and scientific officer, Robert Petit, Ph.D. The three discuss the development and manufacturing of the company’s lead asset, OST-HER2, a Listeria-based immunotherapy for osteosarcoma. They also explain the unique CMC challenges around developing a safe bacterial vector.

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    続きを読む 一部表示
    37 分
  • How J&J Is Tackling Alzheimer's Disease With Fiona Elwood, Ph.D.
    2025/09/24

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Fiona Elwood, Ph.D., VP and Neurodegeneration Disease Area Stronghold Leader at Johnson & Johnson. The two talk about J&J’s end-to-end organizational structure and its modality-agnostic approach to treating Alzheimer’s disease.

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    続きを読む 一部表示
    33 分
  • CDMO Hunger Games And The State Of Biotech With Siren Biotechnology's Nicole Paulk, Ph.D.
    2025/09/10

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Nicole Paulk, Ph.D., CEO and founder of Siren Biotechnology, a company developing a universal AAV immuno-gene therapy for cancer. They discuss the company’s decision to switch from plasmids to producer cell lines (PCLs) in production, the current funding environment for cell and gene therapies (CGTs), how companies are innovating and doing more with less, and the unconventional head-to-head competition that determined which CDMO won Siren’s business.

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    続きを読む 一部表示
    1 時間 1 分
まだレビューはありません